scholarly journals ABCA7 links sterol metabolism to the host defense system: Molecular background for potential management measure of Alzheimer's disease

Gene ◽  
2021 ◽  
Vol 768 ◽  
pp. 145316
Author(s):  
Sumiko Abe-Dohmae ◽  
Shinji Yokoyama
1995 ◽  
Vol 108 (4) ◽  
pp. 1353-1358 ◽  
Author(s):  
W. F. Broekaert ◽  
FRG. Terras ◽  
BPA. Cammue ◽  
R. W. Osborn

2018 ◽  
Vol 71 (12) ◽  
pp. 992-999
Author(s):  
Mitsuyo Horikawa ◽  
Mitsuaki Shimazu ◽  
Maki Aibe ◽  
Hiroto Kaku ◽  
Makoto Inai ◽  
...  

2005 ◽  
Vol 77 (4) ◽  
pp. 665-693 ◽  
Author(s):  
Bruno B. Andrade ◽  
Clarissa R. Teixeira ◽  
Aldina Barral ◽  
Manoel Barral-Netto

The saliva from blood-feeding arthropod vectors is enriched with molecules that display diverse functions that mediate a successful blood meal. They function not only as weapons against host's haemostatic, inflammatory and immune responses but also as important tools to pathogen establishment. Parasites, virus and bacteria taking advantage of vectors' armament have adapted to facilitate their entry in the host. Today, many salivary molecules have been identified and characterized as new targets to the development of future vaccines. Here we focus on current information on vector's saliva and the molecules responsible to modify host's hemostasis and immune response, also regarding their role in disease transmission.


2018 ◽  
Vol 19 (11) ◽  
pp. 3528 ◽  
Author(s):  
Masashi Narazaki ◽  
Tadamitsu Kishimoto

Interleukein-6 (IL-6), is produced locally from infectious or injured lesions and is delivered to the whole body via the blood stream, promptly activating the host defense system to perform diverse functions. However, excessive or sustained production of IL-6 is involved in various diseases. In diseases, the IL-6 inhibitory strategy begins with the development of the anti-IL-6 receptor antibody, tocilizumab (TCZ). This antibody has shown remarkable effects on Castleman disease, rheumatoid arthritis and juvenile idiopathic arthritis. In 2017, TCZ was proven to work effectively against giant cell arteritis, Takayasu arteritis and cytokine releasing syndrome, initiating a new era for the treatment of these diseases. In this study, the defensive functions of IL-6 and various pathological conditions are compared. Further, the diseases of which TCZ has been approved for treatment are summarized, the updated results of increasing off-label use of TCZ for various diseases are reviewed and the conditions for which IL-6 inhibition might have a beneficial role are discussed. Given the involvement of IL-6 in many pathologies, the diseases that can be improved by IL-6 inhibition will expand. However, the important role of IL-6 in host defense should always be kept in mind in clinical practice.


Physiology ◽  
1994 ◽  
Vol 9 (2) ◽  
pp. 80-84 ◽  
Author(s):  
D Piani ◽  
DB Constam ◽  
K Frei ◽  
A Fontana

Cells of the macrophage lineage are ubiquitously distributed in the body, including the central nervous system. They represent an essential host defense system to protect from infections. However, recent evidence indicates that brain macrophages may also be responsible for tissue destruction, including loss of neurons and demyelination.


Gerontology ◽  
1994 ◽  
Vol 40 (5) ◽  
pp. 237-245 ◽  
Author(s):  
Anna Fietta ◽  
Carla Merlini ◽  
Conceiçao Dos Santos ◽  
Sergio Rovida ◽  
Carlo Grassi

Sign in / Sign up

Export Citation Format

Share Document